Summit Therapeutics plc (NASDAQ: SMMT) announces the pricing of its underwritten public offering of 1,459,000 American Depositary Shares at a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE